Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Cardiology/Vascular Diseases | Family Medicine
 Disease Category: Pulmonary Arterial Hypertension
Location: United States, NC

Trial Information

6 week Study for Patients with Pulmonary Hypertension Associated with COPD

The purpose of this study is to confirm the optimal dose of inhaled nitric oxide in patients with Pulmonary Hypertension associated with COPD on oxygen therapy.

Patient Inclusion Criteria:

  • Age 40-80 years
  • Former smokers for at least 1 month
  • Cigarette smoking history of at least 10 pack years
  • Receiving oxygen therapy for at least 10 hours per day for at least 3 months

Patient Exclusion Criteria:

  • Current smokers

Mary Preisel, Marketing/Clinical Research Coordinator
American Health Research
1918 Randolph Rd, Suite 440
Charlotte, NC 28207
Phone: 704-325-6700
Fax: 704-926-8048
Email: Mpreisel@ahres.com

View Map

Research Center Information: American Health Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.